Duhig Kate, Vandermolen Brooke, Shennan Andrew
Women's Health Academic Centre, King's College London, Westminster Bridge Road, London, SE1 7EH, UK.
F1000Res. 2018 Feb 28;7:242. doi: 10.12688/f1000research.12249.1. eCollection 2018.
Pre-eclampsia is a leading cause of maternal mortality, responsible annually for over 60,000 maternal deaths around the globe. Pre-eclampsia is a multisystem disease featuring hypertension, proteinuria, and renal, hepatic, and neurological involvement. Diagnosis is often elusive, as clinical presentation is highly variable. Even those with severe disease can remain asymptomatic. Angiogenic factors are emerging as having a role in the diagnosis of pre-eclampsia and in prognostication of established disease. In this article, we summarize new developments and focus on angiogenic biomarkers for prediction of disease onset. We also discuss recent advances in management strategies for patients with hypertensive disorders of pregnancy.
子痫前期是孕产妇死亡的主要原因,全球每年有超过6万例孕产妇死亡与之相关。子痫前期是一种多系统疾病,其特征为高血压、蛋白尿以及肾脏、肝脏和神经系统受累。由于临床表现高度多变,诊断往往难以捉摸。即使是患有严重疾病的患者也可能没有症状。血管生成因子在子痫前期的诊断和已确诊疾病的预后中发挥着作用。在本文中,我们总结了新进展,并重点关注用于预测疾病发作的血管生成生物标志物。我们还讨论了妊娠高血压疾病患者管理策略的最新进展。